ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE

6334 reported adverse events

Drug classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

These side effects are most commonly reported by patients taking ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 827
1 PAIN 809
2 ANXIETY 757
3 EMOTIONAL DISTRESS 697
4 ANHEDONIA 628
5 CHRONIC KIDNEY DISEASE 473
6 FATIGUE 336
7 DEPRESSION 315
8 RENAL FAILURE 309
9 NAUSEA 306
See all common reactions for ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE

ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE DEMINERALISATION 97 0.0916
1 BLOOD HIV RNA INCREASED 77 0.0424
2 ANHEDONIA 628 0.0239
3 FANCONI SYNDROME ACQUIRED 34 0.0194
4 VIRAL LOAD INCREASED 68 0.0175
5 ECONOMIC PROBLEM 230 0.0152
6 OSTEOPENIA 191 0.0126
7 TEMPERATURE REGULATION DISORDER 24 0.0108
8 CD4 LYMPHOCYTES DECREASED 23 0.0107
9 VIRAL MUTATION IDENTIFIED 39 0.0106
See all enriched reactions for ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE